Clearing Caveat Emptor Issues When History Can Be
Post# of 214
(Total Views: 4105)
Posted On: 03/29/2017 12:23:41 PM
Clearing Caveat Emptor Issues When History Can Be Documented
In some cases these Issuers will be shown as Caveat Emptor on OTC Markets because the previous management did not respond to SEC inquiries even when management could have fully addressed SEC concerns and had the skull and crossbones lifted.
The process of restructuring involves providing transparency to the SEC, FINRA and DTC by bringing past due filings current, and by addressing any open issues such as DTC chills, and SEC inquiries.
If management of the public shell has the proper documentation, removing a skull and crossbones is possible to achieve in a short time with the help of an OTC securities lawyer like Matheau J. W. Stout who can present the information properly.
http://otclawyers.com/shells/
the above was taken from the attorney that reviewed NOUV filings and filed the Attorney Letter with Respect to Current Information.
the Caveat Emptor on OTCMarkets was due to previous management and not from this reverse merger with Entuit Incorporated and (CEO) Jeff Burns. IMO, the attorney and the CEO is working in the background to get the bones removed.
Long $NOUV
In some cases these Issuers will be shown as Caveat Emptor on OTC Markets because the previous management did not respond to SEC inquiries even when management could have fully addressed SEC concerns and had the skull and crossbones lifted.
The process of restructuring involves providing transparency to the SEC, FINRA and DTC by bringing past due filings current, and by addressing any open issues such as DTC chills, and SEC inquiries.
If management of the public shell has the proper documentation, removing a skull and crossbones is possible to achieve in a short time with the help of an OTC securities lawyer like Matheau J. W. Stout who can present the information properly.
http://otclawyers.com/shells/
the above was taken from the attorney that reviewed NOUV filings and filed the Attorney Letter with Respect to Current Information.
the Caveat Emptor on OTCMarkets was due to previous management and not from this reverse merger with Entuit Incorporated and (CEO) Jeff Burns. IMO, the attorney and the CEO is working in the background to get the bones removed.
Long $NOUV
(1)
(0)Nouveau Life Pharmaceuticals Inc (NOUV) Stock Research Links
Scroll down for more posts ▼